|
Jun 18
|
The 13% return this week takes Personalis' (NASDAQ:PSNL) shareholders one-year gains to 394%
|
|
Jun 17
|
Personalis (PSNL) Soars 7.3%: Is Further Upside Left in the Stock?
|
|
Jun 2
|
New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse
|
|
Apr 11
|
With 33% stake, Personalis, Inc. (NASDAQ:PSNL) seems to have captured institutional investors' interest
|
|
Feb 13
|
Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results
|
|
Jan 20
|
Personalis (PSNL) Upgraded to Buy: Here's Why
|